Bank of America
RPRX

Bank of America’s Repros Therapeutics Inc. RPRX Stock Holding History

Bank of America’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,000
Closed -$30K – 8229
2014
Q4 		$30K Sell
3,000
-700
-19% -$5.97K ﹤0.01% 6605
2014
Q3 		$37K Buy
3,700
+700
+23% +$10.4K ﹤0.01% 6720
2014
Q2 		$52K Buy
3,000
+300
+11% +$4.89K ﹤0.01% 6631
2014
Q1 		$48K Sell
2,700
-3,100
-53% -$60K ﹤0.01% 6448
2013
Q4 		$106K Sell
5,800
-126,900
-96% -$2.4M ﹤0.01% 6084
2013
Q3 		$3.56M Sell
132,700
-168,400
-56% -$3.61M ﹤0.01% 2703
2013
Q2 		$5.56M Buy
+301,100
New +$5.32M ﹤0.01% 2198

Bank of America's RPRX Position: Q1 2018 in Review

Bank of America sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 24,992 shares — an estimated $16K sold.

Bank of America first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $4.13M in Q2 2014. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Bank of America reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of America sold 24,992 Repros Therapeutics Inc. shares in Q1 2018, an estimated $16K.
  • Bank of America first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
  • Bank of America's Repros Therapeutics Inc. position peaked at $4.13M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.